Page last updated: 2024-09-03

imatinib mesylate and Mouth Ulcer

imatinib mesylate has been researched along with Mouth Ulcer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chawla, R; Tripathy, K1
Hayakawa, K; Komatsu, T; Tanimoto, T; Tsuda, K1
Basso, FG; Boer, CC; Cintra, ML; Corrêa, ME; da Silva Santos, P; de Magalhães, MH; de Souza, CA; Torrezan, M1
Harn, L; Najera, JE1
de Vries, RA; Mattijssen, V; van der Heijden, AJ; van der Reijden, BA; Verstappen, MC; Wahab, PJ1

Other Studies

5 other study(ies) available for imatinib mesylate and Mouth Ulcer

ArticleYear
Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.
    BMJ case reports, 2017, Nov-23, Volume: 2017

    Topics: Adult; Antineoplastic Agents; Behcet Syndrome; Diagnosis, Differential; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Oral Ulcer; Panuveitis; Retinal Detachment; Steroids

2017
Oral mucosal manifestations of chronic eosinophilic leukaemia with FIP1L1-PDGFRα.
    BMJ case reports, 2016, Jan-12, Volume: 2016

    Topics: Antineoplastic Agents; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Oral Ulcer; Receptor, Platelet-Derived Growth Factor alpha

2016
Skin and oral lesions associated to imatinib mesylate therapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Oral Ulcer; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2009
Chronic eosinophilic leukemia presenting with mouth and penile ulcers.
    The American journal of medicine, 2012, Volume: 125, Issue:8

    Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow Examination; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 4; Diagnosis, Differential; Eosinophils; Gene Fusion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; mRNA Cleavage and Polyadenylation Factors; Oral Ulcer; Penile Diseases; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Ulcer

2012
[A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib].
    Nederlands tijdschrift voor geneeskunde, 2006, May-27, Volume: 150, Issue:21

    Topics: Benzamides; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Oral Ulcer; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha

2006